Exercise Performance With Aficamten vs Metoprolol in oHCM

Дата публикации: 01-08-2026 00:00:00

This randomized clinical trial assesses the use of aficamten vs metoprolol for exercise in patients with obstructive hypertrophic cardiomyopathy.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Metformin Use and Age-Related Macular Degeneration in Patients With Diabetes	0	9.02	01-07-2026
2	Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk	0	7.22	01-08-2026
3	Right Ventricular Metrics as End Points in Clinical Trials	0	5.8	01-08-2026
4	Twenty-Five–Year Follow-Up of Quantified Mitral Regurgitation	0	15.41	29-07-2026
5	AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia	0	9.08	01-08-2026
6	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026
7	Cost Offset With Quadruple Therapy for Heart Failure	0	9.43	01-08-2026
8	Abnormal Echocardiogram in the Setting of Malignancy	0	7.83	01-08-2026
9	Seven-Year Valve Durability With TAVR	0	11.52	01-08-2026
10	Music Listening and Multiple Dimensions of Well-Being in Acute Stroke	0	11.68	17-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.05. Источник: archderm.jamanetwork.com.